Page 32«..1020..31323334..4050..»

Category Archives: Ulcerative Colitis

2020 Ulcerative Colitis Market Report Share, Types, Region and Overview 2025 – Instanews247

Posted: Published on January 11th, 2020

ReportsnReports has recently added a new research report to its expanding repository. The research report, titled Ulcerative Colitis Market, offers a clear understanding of the subject matter. Continue reading

Posted in Ulcerative Colitis | Comments Off on 2020 Ulcerative Colitis Market Report Share, Types, Region and Overview 2025 – Instanews247

Sorrento Announces Filing for Approval of Infliximab Biobetter Antibody by Its Partner Mabpharm in China – Yahoo Finance

Posted: Published on January 11th, 2020

SAN DIEGO, Jan. Continue reading

Posted in Ulcerative Colitis | Comments Off on Sorrento Announces Filing for Approval of Infliximab Biobetter Antibody by Its Partner Mabpharm in China – Yahoo Finance

Ulcerative Colitis Market Projected to Exhibit a High Single-Digit CAGR through 2026 – Food & Beverage Herald

Posted: Published on January 11th, 2020

The Ulcerative ColitisMarketreport focus on the current trends of the market along with detailed analysis which provides data regarding this market rate, and it also predicts the future market growth rate. The Ulcerative Colitis Market study includes research on the top markets based on all the data from the elite players, current, past and future. Major companies in the Ulcerative Colitis were identified through the second survey and market share was determined through the first and second surveys. Continue reading

Posted in Ulcerative Colitis | Comments Off on Ulcerative Colitis Market Projected to Exhibit a High Single-Digit CAGR through 2026 – Food & Beverage Herald

Mabpharm Seeks Approval of Infliximab Biobetter in China – Ankylosing Spondylitis News

Posted: Published on January 11th, 2020

Mabpharm has filed an application with Chinas National Medical Products Administration (NMPA) seeking approval of a biobetter of infliximab, a biological treatment for people with ankylosing spondylitisand other inflammatory disorders. Sorrento Therapeutics, the company owning global rights to the biobetter antibody outside of China, plans to file a biologics license application in the United States for the same purpose. Continue reading

Posted in Ulcerative Colitis | Comments Off on Mabpharm Seeks Approval of Infliximab Biobetter in China – Ankylosing Spondylitis News

Xeljanz XR Approved for Ulcerative Colitis – Monthly Prescribing Reference

Posted: Published on December 19th, 2019

The Food and Drug Administration (FDA) has approved Xeljanz XR (tofacitinib extended-release; Pfizer) for the treatment of adult patients with moderately to severely active ulcerative colitis (UC), who have an inadequate response or who are intolerant to tumor necrosis factor blockers. The approval of Xeljanz XR, which is available in 11mg and 22mg extended-release tablets, was based on data obtained from clinical trials evaluating Xeljanz (tofacitinib) in adult patients with moderately to severely active UC. The extended-release formulation now allows for once-daily dosing for induction and maintenance therapy. Continue reading

Posted in Ulcerative Colitis | Comments Off on Xeljanz XR Approved for Ulcerative Colitis – Monthly Prescribing Reference

For Ulcerative Colitis, Extended-Release Xeljanz XR Approved by FDA – IBD News Today

Posted: Published on December 19th, 2019

The U.S. Continue reading

Posted in Ulcerative Colitis | Comments Off on For Ulcerative Colitis, Extended-Release Xeljanz XR Approved by FDA – IBD News Today

Weight Loss and Parkinson’s Disease – Parkinson’s News Today

Posted: Published on December 19th, 2019

Dad used to tell us that he has two sets of clothes: a normal set and a set of skinny clothes that emerge when he gets sick. Continue reading

Posted in Ulcerative Colitis | Comments Off on Weight Loss and Parkinson’s Disease – Parkinson’s News Today

Seven Practice-Changing Studies You Need to Know: ACG 2019 – Medscape

Posted: Published on December 19th, 2019

This transcript has been edited for clarity. Hello. Continue reading

Posted in Ulcerative Colitis | Comments Off on Seven Practice-Changing Studies You Need to Know: ACG 2019 – Medscape

FDA Approves XELJANZ XR (tofacitinib) Extended-Release Tablets for the Treatment of Ulcerative Colitis – Business Wire

Posted: Published on December 19th, 2019

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today that the U.S. Continue reading

Posted in Ulcerative Colitis | Comments Off on FDA Approves XELJANZ XR (tofacitinib) Extended-Release Tablets for the Treatment of Ulcerative Colitis – Business Wire

Spinathon raises money to fight Crohn’s and colitis – New Jersey Hills

Posted: Published on December 19th, 2019

MENDHAM TWP. About 70 riders joined a spinathon at Cyclebar in Bernardsville on Dec. 8 to pedal for the Crohns and Colitis Foundation. Continue reading

Posted in Ulcerative Colitis | Comments Off on Spinathon raises money to fight Crohn’s and colitis – New Jersey Hills

Page 32«..1020..31323334..4050..»